Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/GINKGO-BIOWORKS-HOLDINGS--127173269/news/Ginkgo-Bioworks-NYSE-DNA-hat-die-Ubernahme-der-Zelltherapieplattform-von-Modulus-Therapeutics-ab-46342620/?utm_source=whatsapp&utm_medium=social&utm_campaign=share